PharmaCell is a leading European-based Contract Manufacturing Organization (CMO) exclusively focused in the area of cell therapy and regenerative medicine. PharmaCell has experience in supporting Phase I through Phase III clinical trials and early commercial manufacturing in cell therapy in terms of manufacturing, Quality Control, storage, in-outgoing logistics and product release.
PharmaCell – cell therapy and regenerative medicine CMO
Ocata therapeutics is a clinical stage biopharma company developing regenerative medicine and cell therapy technologies. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration and myopic macular degeneration.
Ocata therapeutics – regenerative ophthalmology
ProFibrix is a biotech company specialized in fibrinogen technology to develop innovative products for the hemostasis and regenerative medicine markets.
ProFibrix – fibrinogen technology
Regeneus is a biotech company developing and commercializing proprietary technologies for the preparation of cell therapies for the treatment of musculoskeletal and other inflammatory conditions in humans and animals.